Andrographolide Derivatives for Hepatitis C Liver Protection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for Hepatitis C virus (HCV) infection are limited, with existing therapies showing low efficacy and no effective vaccines available, and there is a need for alternative medications that can effectively prevent liver damage caused by HCV and other liver diseases.
Innovation Solution
Development of 15-benzylidene-14-deoxy-11,12-dehydroandrographolide derivatives, which are synthesized and tested for their hepatoprotective and anti-HCV activities, demonstrating significant suppression of liver damage and low toxicity, potentially leading to the creation of new anti-HCV and hepatoprotective drugs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If interferon therapy or combined therapy with ribavirin is used for HCV treatment, then antiviral effect is achieved, but treatment efficacy is limited and HCV remains in half of patients
Solution Approach 1:
The patent modifies the chemical structure of andrographolide by introducing specific substituents at positions 1, 2, 3, and 15 of the andrographolide core structure. These structural parameter changes result in derivatives with enhanced antiviral activity against HCV, overcoming the limitation of conventional interferon therapy in achieving complete viral clearance.
Solution Approach 2:
The invention combines the andrographolide scaffold with various aromatic substituents (such as fluorophenyl, chlorophenyl, bromophenyl groups) to create composite molecular structures. This composite approach yields derivatives that exhibit synergistic antiviral effects, improving upon the limited efficacy of existing HCV treatments.
2Reliability
If andrographolide and its derivatives are used for liver protection, then protective effect against liver damage is achieved, but the mechanism involves complex interactions with multiple pathways
Solution Approach 1:
The patent extracts and isolates the specific andrographolide derivatives with optimized structures from the complex mixture of andrographolide components. By focusing on specific molecular structures with defined substituents, the invention simplifies the active components while maintaining the multi-pathway hepatoprotective effects against liver damage.
3Adaptability or versatility
If new anti-HCV medications are developed, then alternative treatment options are provided, but development time and research resources are required
Solution Approach 1:
The patent performs preliminary structure-activity relationship studies by systematically synthesizing and evaluating multiple andrographolide derivatives with different substituents. This preliminary action identifies the most promising derivatives with enhanced antiviral activity, accelerating the drug development process by pre-screening candidates before clinical evaluation.
Data Source
AI summary
Disclosed is use of andrographolide derivative as shown by general formula 1 in manufacture of medicaments for anti-hepatitis C virus, and preventing and treating immunological liver damage caused by virus infection and different chemical liver damage.